Search

Search Results

• Advances in immunology and rheumatoid arthritis pathogenesis

  G. Valesini, F. Barone, D. Bompanone, M. Catuogno, A. Sili Scavalli

  9-20

  Published:

  1924

• Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)

  V. Bruzzese, J. Pepe

  306-308

  Published:

  917

  PDF: 744

• Citrullination: the loss of tolerance and development of autoimmunity in rheumatoid arthritis

  S. Alivernini, A.L. Fedele, I. Cuoghi, B. Tolusso, G. Ferraccioli

  85-94

  Published:

  1350

  PDF: 1049

• Rheumatoid arthritis: frequency of hospitalization and evaluation of economic burden

  A. Ciocci, L. Buratti, G. Coari, M. Di Franco, A.M. Iagnocco, M.T. Mauceri, A. Serio

  215-222

  Published:

  1036

  PDF: 713
• 

  Occult axial involvement in patients with psoriatic arthritis mutilans: a case report

  F.M. Perrotta, S. Scriffignano, A. De Socio, E. Lubrano

  88-91

  09-07-2019

  Published: 9 July 2019

  1753

  PDF: 862

• Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature

  R. Scrivo, F. Conti, F.R. Spinelli, S. Truglia, L. Magrini, M. Di Franco, F. Ceccarelli, G. Valesini

  107-117

  Published:

  1815

  PDF: 1067

• Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

  A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

  121-126

  Published:

  1648

  PDF: 1654

• IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

  U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

  62-73

  Published:

  1200

  PDF: 1867

• Case report: rheumatoid arthritis and large granular lymphocytes syndrome

  F. Ingegnoli, M. Arreghini, B. Panni, R. Capra, F. Galbiati, P. Bonara, A. Marchesoni

  357-360

  Published:

  1026

  PDF: 2081
• 

  The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

  S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

  78-84

  06-07-2018

  Published: 6 July 2018

  2356

  PDF: 1228

• Safety of rituximab in rheumatoid arthritis

  M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

  101-106

  Published:

  1586

  PDF: 960

• Sustained response to infliximab treatment in two cases of early rheumatoid arthritis that has been maintained after drug withdrawal

  P. Caramaschi, S. Pieropan, A. Volpe, A. Carletto, L.M Bambara, D. Biasi

  221-223

  Published:

  737

  PDF: 1295

• Prevalence of rheumatoid arthritis in North Sardinia: the Tempio Pausania’s study

  D. Marotto, M.E. Nieddu, A. Cossu, A. Carcassi

  273-276

  Published:

  738

  PDF: 2151

• B Lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis

  L. Quartuccio, M. Fabris, G. Ferraccioli

  143-146

  Published:

  1382

  PDF: 1007

• TNF-α gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-α agents: preliminary results

  M. Fabris, E. Di Poi, S. Sacco, G. Damante, L. Sinigaglia, G. Ferraccioli

  19-26

  Published:

  1215

  PDF: 722
• 

  Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

  M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

  16-20

  10-04-2020

  Published: 10 April 2020

  1247

  PDF: 662

• Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

  A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

  233-238

  Published:

  981

  PDF: 955

• Kidney involvement in rheumatoid arthritis

  A. Icardi, P. Araghi, M. Ciabattoni, U. Romano, P. Lazzarini, G. Bianchi

  76-85

  Published:

  5284

  PDF: 7481
• 

  Treatment patterns of snti-TNF agents in Italy: an observational study

  L. Punzi, M. Matucci Cerinic, F. Cantini, G. Bagnato, U. Fiocco, C. Ferri, S. Bombardieri

  18-28

  Published:

  1239

  PDF: 914

• Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

  P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

  290-295

  Published:

  1987

  PDF: 1035

• The psoriatic great toe or the psoriatic onycho-pachydermo-periostitis of great toe (OP3gt)

  R. Ramonda, P. Zucchetta, C. Contessa, L. Punzi

  282-285

  Published:

  1208

  PDF: 1846
• 

  Jaccoud’s arthropathy, an unusual manifestation of idiopathic retroperitoneal fibrosis: rapid improvement of symptoms after tocilizumab treatment

  M. Benucci, A. Damiani, F. Li Gobbi, V. Grossi, M. Infantino, A. Arena, M. Manfredi

  88-91

  03-08-2017

  Published: 3 August 2017

  1845

  PDF: 915

• Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

  M.G. Portuesi, P. Perosa

  61-63

  Published:

  1118

  PDF: 843

• Temporomandibular joint involvement in juvenile idiopathic arthritis: treatment with an orthodontic appliance

  C. Bellintani, P. Ghiringhelli, V. Gerloni, M. Gattinara, G. Farronato, F. Fantini

  201-207

  11-04-2005

  Published: 11 April 2005

  1412

  PDF: 1767

• Anti-chromatin antibodies in juvenile rheumatoid arthritis

  F. Ingegnoli, N. Del Papa, E. Lupi, D.P. Comina, W. Maglione, V. Gerloni, F. Fantini

  240-244

  Published:

  1164

  PDF: 925

• Stress response system and personality in rheumatoid arthritis patients

  C. Prete, F. Briano, C. Pizzorni, A. Sulli, M. Marcenaro, M. Cutolo

  204-209

  Published:

  1311

  PDF: 859

• Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis

  M. Gutierrez, E. Filippucci, L. Bugatti, C. Bertolazzi, W. Grassi

  65-68

  Published:

  1284

  PDF: 951

• Therapeutic gene transfer for rheumatoid arthritis

  M.C. Boissier, N. Bessis

  51-61

  Published:

  654

  PDF: 669

• Anti-tissue transglutaminase antibodies in inflammatory and degenerative arthropathies

  A. Spadaro, M.L. Sorgi, R. Scrivo, A. Picarelli, M. Di Tola, L. Sabbatella, E. Taccari

  344-350

  Published:

  1039

  PDF: 1614
• 

  Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases

  G. El Hasbani, A. Jawad, I. Uthman

  59-63

  19-04-2021

  Published: 19 April 2021

  4941

  PDF: 1290

• Knee radiosynovectomy with Y90 in patients with rheumatoid arthritis: our experiences

  W. Troise Rioda, A. Nervetti, G. Ugolotti, G. Adorni

  206-211

  Published:

  1034

  PDF: 1789

• Synoviocyte cultures from synovial fluid

  A. Scanu, F. Oliviero, L. Braghetto, R. Ramonda, R. Luisetto, F. Calabrese, A. Pozzuoli, L. Punzi

  66-70

  Published:

  1562

  PDF: 1000

• Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

  I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

  267-272

  Published:

  996

  PDF: 1548

• Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

  L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

  182-186

  Published:

  961

  PDF: 664

• short history of anti-rheumatic therapy. IV. Corticosteroids

  G. Pasero, P. Marson

  292-299

  Published:

  1673

  PDF: 1744

• Atherosclerosis and rheumatoid arthritis: relationships between intima-media thickness of the common carotid arteries and disease activity and disabilty

  G. Cuomo, P. Di Micco, A. Niglio, G. La Montagna, G. Valentini

  242-246

  Published:

  1446

  PDF: 1241
• 

  Hand dominance in early and established rheumatoid arthritis: evaluation by dynamometer, Ritchie index and musculoskeletal ultrasound: a cross sectional study

  A.M. Elsaman, A. Sayed, A.R. Radwan

  131-144

  19-11-2020

  Published: 19 November 2020

  1072

  PDF: 642

• Cardiac involvement in rheumatoid arthritis

  M. Turiel, S. Sitia, L. Tomasoni, S. Cicala, F. Atzeni, L. Gianturco, M. Longhi, V. De Gennaro Colonna, P. Sarzi-Puttini

  244-253

  Published:

  1837

  PDF: 1270

• Tenosynovitis of the ankles as onset of sarcoidosis in a patient with ulcerative colitis

  A. Furlan, M. Podswiadek, F. Cozzi, S. Todesco

  197-200

  11-04-2005

  Published: 11 April 2005

  1351

  PDF: 1358

• Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations

  D. Biscontini, E. Bartoloni Bocci, R. Gerli

  48-53

  Published:

  1336

  PDF: 928

• Reconstructing the pyramid as a therapeutic approach to rheumatoid arthritis

  G. Ferraccioli

  46-50

  Published:

  653

  PDF: 635
• 

  Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs

  L. Degli Esposti, V. Perrone, D. Sangiorgi, L. Sinigaglia

  5-14

  19-04-2021

  Published: 19 April 2021

  3476

  PDF: 487

• Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

  G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini

  50-56

  Published:

  1078

  PDF: 720

• Diff-Quik® staining method for detection and identification of monosodium urate and calcium pyrophosphate crystals in synovial fluids

  S. Manganelli, E. Selvi, M. Catenaccio, S. Cucini, R. De Stefano, E. Frati, M. Hammoud, R. Marcolongo

  305-308

  Published:

  1337

  PDF: 796
• 

  Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

  C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

  19-12-2023

  Published: 19 December 2023

  1550

  PDF: 348
• 

  Treatment of hyperuricemia, gout and other crystalline arthritidies

  F. Lioté

  276-283

  Published:

  1067

  PDF: 996

• Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity

  E. Bartoloni Bocci, S. Marchesi, F. Delle Monache, G. Vaudo, A. Giordano, F. Ragni Alunni, C. Angrisani, E. Mannarino, Y. Shoenfeld, R. Gerli

  16-21

  Published:

  902

  PDF: 822

• Hidden bone erosions

  E. Filippucci, A. Farina, F. Salaffi, W. Grassi

  52-55

  Published:

  998

  PDF: 4727
• 

  Extra-articular rheumatoid arthritis

  E. Marcucci, E. Bartoloni, A. Alunno, M.C. Leone, G. Cafaro, F. Luccioli, V. Valentini, E. Valentini, G.M.C. La Paglia, A.F. Bonifacio, R. Gerli

  212-224

  20-12-2018

  Published: 20 December 2018

  7915

  PDF: 4171

• Leishmaniasis in rheumatoid arthritis

  C. Pizzorni, M.E. Secchi, M. Cutolo

  235-239

  Published:

  1421

  PDF: 904